Cutaneous Immune Mapping: Enhance Treatment Efficacy Using Validated Biomarkers
Time: 11:30 am
day: Day One
Details:
- Understand unique properties of circulating CLA+ memory T cells as cellular biomarkers in AD
- Explore how circulating CLA+ T cells are involved in monitoring treatment response in AD
- Discover how CLA+ T cell allow functionally stratifying IL-13, IL-31, IL-9 and IL-22 responders in moderate-severe AD
